Evoke Pharma Stock Price on May 31, 2024
| EVOK Stock | USD 4.10 0.02 0.49% |
Below is the normalized historical share price chart for Evoke Pharma extending back to September 25, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Evoke Pharma stands at 4.10, as last reported on the 12th of December 2024, with the highest price reaching 4.22 and the lowest price hitting 4.03 during the day.
If you're considering investing in Evoke Stock, it is important to understand the factors that can impact its price. As of now, Evoke Stock is risky. Evoke Pharma secures Sharpe Ratio (or Efficiency) of 0.016, which denotes the company had a 0.016% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Evoke Pharma, which you can use to evaluate the volatility of the firm. Please confirm Evoke Pharma's Mean Deviation of 3.81, coefficient of variation of 3548.88, and Downside Deviation of 5.08 to check if the risk estimate we provide is consistent with the expected return of 0.1%.
At this time, Evoke Pharma's Common Stock Total Equity is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 10.1 M this year, although the value of Other Stockholder Equity will most likely fall to about 75.9 M. . The value of Price To Sales Ratio is estimated to slide to 0.64. The value of Price Earnings Ratio is estimated to slide to -0.47. Evoke Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of September 2013 | 200 Day MA 5.726 | 50 Day MA 5.0565 | Beta 0.348 |
Evoke |
Sharpe Ratio = 0.016
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | EVOK | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.29 actual daily | 56 56% of assets are less volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Evoke Pharma is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Evoke Pharma by adding it to a well-diversified portfolio.
Price Book 1.3888 | Enterprise Value Ebitda (0.36) | Price Sales 0.707 | Shares Float 969.5 K | Wall Street Target Price 18 |
Related Headline
Cumberland Pharmaceuticals Headline on 31st of May 2024
Filed transaction by Cumberland Pharmaceuticals Director, 10 Percent Owner, Officer Chairman And Ceo. Grant, award or other acquisition pursuant to Rule 16b-3
Evoke Pharma Valuation on May 31, 2024
It is possible to determine the worth of Evoke Pharma on a given historical date. On May 31, 2024 Evoke was worth 5.09 at the beginning of the trading date compared to the closed value of 5.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Evoke Pharma stock. Still, in general, we apply an absolute valuation method to find Evoke Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Evoke Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Evoke Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 5.52 | 5.52 | 5.14 | 5.17 | 998.00 | |
05/31/2024 | 5.09 | 6.00 | 5.09 | 5.70 | 955.00 |
| 5.98 | 6.48 | 5.88 | 6.06 | 2,478 |
| Backtest Evoke Pharma | | | Evoke Pharma History | | | Evoke Pharma Valuation | Previous | Next |
Evoke Pharma Trading Date Momentum on May 31, 2024
| On June 03 2024 Evoke Pharma was traded for 6.06 at the closing time. The top price for the day was 6.48 and the lowest listed price was 5.88 . The trading volume for the day was 2.5 K. The trading history from June 3, 2024 was a factor to the next trading day price upswing. The overall trading delta against the next closing price was 6.32% . The overall trading delta against the current closing price is 23.68% . |
Evoke Pharma Fundamentals Correlations and Trends
By evaluating Evoke Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Evoke Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Evoke financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Evoke Pharma Stock history
Evoke Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Evoke is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Evoke Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Evoke Pharma stock prices may prove useful in developing a viable investing in Evoke Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 278.6 K | 264.7 K | |
| Net Loss | -7.4 M | -7.8 M |
Evoke Pharma Quarterly Net Working Capital |
|
Evoke Pharma Stock Technical Analysis
Evoke Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Evoke Pharma Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Evoke Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Evoke Pharma December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Evoke Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Evoke Pharma shares will generate the highest return on investment. By undertsting and applying Evoke Pharma stock market strength indicators, traders can identify Evoke Pharma entry and exit signals to maximize returns
Evoke Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Evoke Pharma's price direction in advance. Along with the technical and fundamental analysis of Evoke Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Evoke to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0292 | |||
| Jensen Alpha | 0.0378 | |||
| Total Risk Alpha | (0.82) | |||
| Sortino Ratio | 0.0098 | |||
| Treynor Ratio | 0.1487 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evoke Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Evoke Stock please use our How to buy in Evoke Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evoke Pharma. If investors know Evoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evoke Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.13) | Revenue Per Share 7.792 | Quarterly Revenue Growth 0.698 | Return On Assets (0.34) | Return On Equity (3.50) |
The market value of Evoke Pharma is measured differently than its book value, which is the value of Evoke that is recorded on the company's balance sheet. Investors also form their own opinion of Evoke Pharma's value that differs from its market value or its book value, called intrinsic value, which is Evoke Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evoke Pharma's market value can be influenced by many factors that don't directly affect Evoke Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evoke Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evoke Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evoke Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.